Abstract
Background: Malignant pleural mesothelioma (MPM) is a rare but fatal tumour. Although most MPM patients show pleural effusion at even the early stage, it is hard to diagnose as MPM at the early stage because a sensitive and reliable diagnostic marker for MPM has not been found in plasma or pleural effusion. Methods: In this study, we investigated whether intelectin-1 was specifically contained in MPM cells and the pleural effusion of MPM patient by immunohistochemistry, western blotting, and enzyme-linked immunosorbent assay. Results: Malignant pleural mesothelioma cell lines, but not lung adenocarcinoma cell lines, secreted intelectin-1. In immunohistochemistry, epithelioid-type MPMs, but neither pleura-invading lung adenocarcinomas nor reactive mesothelial cells near the lung adenocarcinomas, were stained with anti-intelectin antibodies. Pleural effusion of MPM patients contained a higher concentration of intelectin-1 than that of lung cancer patients.Conclusion:These results suggest that detection of intelectin-1 may be useful for a differential diagnosis of epithelioid-type MPM in immunohistochemistry and that a high concentration of intelectin-1 in pleural effusion can be used as a new marker for clinical diagnosis of MPM. © 2010 Cancer Research UK All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Tsuji, S., Tsuura, Y., Morohoshi, T., Shinohara, T., Oshita, F., Yamada, K., … Miyagi, Y. (2010). Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. British Journal of Cancer, 103(4), 517–523. https://doi.org/10.1038/sj.bjc.6605786
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.